48 /100
MEDIUM RISK
Score updated May 16, 2026

NXTT — Next Technology Holding Inc. Dilution Risk Tracker

Track NXTT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NXTT — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
12
⚠️ Warrant Exposure
90
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
42%
📜 Warrant Exercise 60%
• Massive warrant overhang: 45% of shares outstanding
• Warrant risk score very high (90/100)
🔄 Reverse Split 30%
• 50-day avg $1.87 approaching $1 threshold
💰 Capital Raise 18%
• Active ATM program with $500M remaining capacity
🔔 Track NXTT — Get forecast alerts →

💹 Market Data

Market Cap$118.21M
Shares Outstanding76.26M
Float74.13M
Cash$159.72M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 48.7K shares
#1 DRW Securities, LLC 30.3K shares
#2 Bridgeway Capital Management, LLC 10.1K shares
#3 UBS Group AG 6.3K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest88.3K
Days to Cover1.0
% of Float0.1%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Sep 30, 2025
8-K 8K EVENT Mar 27, 2026
424B5 ATM Mar 25, 2026
8-K 8K EVENT Mar 25, 2026
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track NXTT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NXTT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for NXTT
📊 NXTT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NXTT Signal Convergence & Dark Pool Activity — StonkWhisper 📄 NXTT Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.